Weight-loss jabs could have a hidden benefit for a particular group of breast cancer patients, a new study has found.
Scientists studying the “overlooked” hormone estrone, which is produced in fat tissue, have said it could be linked to an increased risk of death from breast cancer in postmenopausal women with obesity.